- Home
- VRA vs STTK Comparison
VRA vs STTK Comparison
Compare VRA & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRA
- STTK
- Stock Information
- Founded
- VRA 1982
- STTK 2016
- Country
- VRA United States
- STTK United States
- Employees
- VRA N/A
- STTK N/A
- Industry
- VRA Apparel
- STTK Biotechnology: Pharmaceutical Preparations
- Sector
- VRA Consumer Discretionary
- STTK Health Care
- Exchange
- VRA Nasdaq
- STTK Nasdaq
- Market Cap
- VRA 61.7M
- STTK 37.6M
- IPO Year
- VRA 2010
- STTK 2020
- Fundamental
- Price
- VRA $2.35
- STTK $0.83
- Analyst Decision
- VRA Strong Buy
- STTK Hold
- Analyst Count
- VRA 2
- STTK 4
- Target Price
- VRA $4.00
- STTK $3.00
- AVG Volume (30 Days)
- VRA 566.8K
- STTK 423.3K
- Earning Date
- VRA 06-11-2025
- STTK 07-31-2025
- Dividend Yield
- VRA N/A
- STTK N/A
- EPS Growth
- VRA N/A
- STTK N/A
- EPS
- VRA N/A
- STTK N/A
- Revenue
- VRA $355,671,000.00
- STTK $4,606,000.00
- Revenue This Year
- VRA N/A
- STTK N/A
- Revenue Next Year
- VRA $3.80
- STTK N/A
- P/E Ratio
- VRA N/A
- STTK N/A
- Revenue Growth
- VRA N/A
- STTK 69.65
- 52 Week Low
- VRA $1.71
- STTK $0.69
- 52 Week High
- VRA $6.99
- STTK $4.99
- Technical
- Relative Strength Index (RSI)
- VRA 57.02
- STTK 38.86
- Support Level
- VRA $2.35
- STTK $0.75
- Resistance Level
- VRA $2.54
- STTK $0.85
- Average True Range (ATR)
- VRA 0.17
- STTK 0.09
- MACD
- VRA 0.03
- STTK -0.01
- Stochastic Oscillator
- VRA 77.87
- STTK 9.59
About VRA Vera Bradley Inc.
Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.